Clinical Trials for Agenus

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

"The Miami EMPIRE Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation"

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

The Seven Trial: Exploiting the Unfolded Protein Response

A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

Botensilimab and Balstilimab Optimization in Colorectal Cancer

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer